Cover Image

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia-A Meta-Analysis

Introduction: Combination therapy with daptomycin plus ceftaroline to treat methicillin-resistant <i>Staphylococcus aureus</i> bacteremia has been reported to reduce methicillin-resistant <i>Staphylococcus aureus</i> bacteremia-related mortality. The purpose of the current me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chienhsiu Huang (Author), Ihung Chen (Author), Lichen Lin (Author)
Format:	Book
Published:	MDPI AG, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Septic thrombophlebitis with persistent methicillin-resistant Staphylococcus aureus bacteremia and de novo resistance to vancomycin and daptomycin
by: Yael Koton, et al.
Published: (2017)

Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: A Systematic Review and Meta-Analysis
by: Hitoshi Kawasuji, et al.
Published: (2023)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant <i>Staphylococcus</i> <i>aureus</i> with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
by: Masaru Samura, et al.
Published: (2022)

In Vivo-Acquired Resistance to Daptomycin during Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
by: Adeline Boutet-Dubois, et al.
Published: (2023)

Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis
by: Alberto Enrico Maraolo, et al.
Published: (2021)

Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis
by: Xiaonan Xu, et al.
Published: (2022)

Adaptive Laboratory Evolution of <i>Staphylococcus aureus</i> Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance
by: Vladimir Gostev, et al.
Published: (2023)

Comparative Genomics Identifies Novel Genetic Changes Associated with Oxacillin, Vancomycin and Daptomycin Susceptibility in ST100 Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Sabrina Di Gregorio, et al.
Published: (2023)

Daptomycin-Vancomycin-Resistant Native Valve Endocarditis
by: Khandakar Hussain MD, et al.
Published: (2016)

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
by: Mori T, et al.
Published: (2012)

Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2020)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
by: Alexandra G. Mills, et al.
Published: (2023)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
by: Zarogoulidis P, et al.
Published: (2014)

Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy
by: Celia Permuy, et al.
Published: (2023)

A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Infections
by: Nicole Lounsbury, et al.
Published: (2019)

A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
by: Hideo Kato, et al.
Published: (2022)

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
by: Stephens JM, et al.
Published: (2013)

Catalase Protects Biofilm of <i>Staphylococcus aureus</i> against Daptomycin Activity
by: Cristina El Haj, et al.
Published: (2021)

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
by: Tong J, et al.
Published: (2021)

The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection
by: Yu-Chung Chuang, et al.
Published: (2022)

The Role of Subinhibitory Concentrations of Daptomycin and Tigecycline in Modulating Virulence in <i>Staphylococcus aureus</i>
by: Salman Sahab Atshan, et al.
Published: (2021)

The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant <i>Staphylococcus aureus</i>
by: Md Saruar Bhuiyan, et al.
Published: (2021)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination Therapy
by: Taylor Morrisette, et al.
Published: (2020)

Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
by: Davie Wong, et al.
Published: (2020)

Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study
by: Jennifer Hammond, et al.
Published: (2024)

Susceptibility to methicillin and vancomycin in Staphylococcus aureus isolated from blood cultures
by: Maribel Josefina Castellano-González, et al.
Published: (2020)

The Role of ArlRS and VraSR in Regulating Ceftaroline Hypersusceptibility in Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Maite Villanueva, et al.
Published: (2021)

Daptomycin for methicillin-resistant <it>Staphylococcus epidermidis </it>native-valve endocarditis: a case report
by: Duah Marylene
Published: (2010)

Molecular Basis of Methicillin and Vancomycin Resistance in <i>Staphylococcus aureus</i> from Cattle, Sheep Carcasses and Slaughterhouse Workers
by: Hanan A. Zaher, et al.
Published: (2023)

Methicillin- and vancomycin-resistant Staphylococcus aureus in health care workers and medical devices
by: Angela Breves, et al.
Published: (2015)

Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group IIA-Secreted Phospholipase A2 and Daptomycin
by: Marieke M. Kuijk, et al.
Published: (2022)

Spontaneous bacterial peritonitis due to methicillin-resistant Staphylococcus aureus in a patient with cirrhosis: the potential role for daptomycin and review of the literature
by: Marco Falcone, et al.
Published: (2015)

Daptomycin-Impregnated PMMA Cement against Vancomycin-Resistant Germs: Dosage, Handling, Elution, Mechanical Stability, and Effectiveness
by: Martina Humez, et al.
Published: (2023)

Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach
by: Vivian Garzon, et al.
Published: (2024)

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>
by: Katie E. Barber, et al.
Published: (2021)

Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India
by: Avinash Singh, et al.
Published: (2015)

Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it>Staphylococcus aureus </it>in a renal transplant recipient with Fabry-Anderson disease
by: Polilli Ennio, et al.
Published: (2012)

Epidemiology of <i>Staphylococcus aureus</i> Non-Susceptible to Vancomycin in South Asia
by: Mohammad Ejaz, et al.
Published: (2023)

Persistent Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: Host, Pathogen, and Treatment
by: Joshua B. Parsons, et al.
Published: (2023)

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
by: Marguerite L. Monogue, et al.
Published: (2018)